IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Ambit Biosciences Corporation


USPTO Granted Patents = 39



Forward Citations = 110

Loading Chart...
Loading Chart...

76 inventors (with patents filed for the assignee):

goldMedal Mark W Holladay (17 out of 25 patents)

silverMedal Eduardo Setti (12 out of 19 patents)

bronzeMedal Qi Chao (11 out of 26 patents)

4.  Martin W Rowbottom (10 out of 41 patents)

5.  Shripad S Bhagwat (9 out of 43 patents)

6.  Sunny Abraham (8 out of 16 patents)

7.  Gang Liu (8 out of 65 patents)

8.  Kelly G Sprankle (7 out of 22 patents)

9.  Michael J Hadd (7 out of 14 patents)

10.  Andiliy Gokching Lai (7 out of 19 patents)

11.  David J Lockhart (6 out of 60 patents)

12.  Brian T Campbell (5 out of 17 patents)

13.  Raffaella Faraoni (5 out of 5 patents)

14.  Hitesh K Patel (5 out of 6 patents)

15.  Pietro Ciceri (4 out of 6 patents)


39 patents:

1. 10053430 - RAF kinase modulator compounds and methods of use thereof (2018-08-21),
2. 9938261 - Heterocyclic compounds and methods of use thereof (2018-04-10),
3. 9730937 - RAF kinase modulator compounds and methods of use thereof (2017-08-15),
4. 9725465 - Biaryl acetamide compounds and methods of use thereof (2017-08-08),
5. 9675549 - Tablet containing composite with cyclodextrin (2017-06-13),
6. 9611253 - Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith (2017-04-04),
7. 9585892 - Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith (2017-03-07),
8. 9555040 - Methods of treating proliferative diseases (2017-01-31),
9. 9452167 - Heterocyclic compounds and methods of use thereof (2016-09-27),
10. 9320739 - RAF kinase modulator compounds and methods of use thereof (2016-04-26),
11. 9308207 - JAK kinase modulating compounds and methods of use thereof (2016-04-12),
12. 9296722 - Azolyl urea compounds and methods of use thereof (2016-03-29),
13. 9295672 - Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof (2016-03-29),
14. 9284332 - Process for the preparation of imidazo[2,1-B][1,3]benzothiazole derivatives (2016-03-15),
15. 8969587 - RAF kinase modulator compounds and methods of use thereof (2015-03-03),
Ambit Biosciences Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule kinase inhibitors for the treatment of cancer and other life-threatening diseases. Using their proprietary kinase profiling platform, Ambit identifies and develops targeted therapies that have the potential to improve patient outcomes. With a diverse pipeline of drug candidates, Ambit is dedicated to advancing precision medicine and transforming healthcare.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
39 Patents

#147 in San Diego, CA

#2,030 in California

#8,535 in US

#16,914 in the World

...
San Diego, CA, United States of America

Ambit Biosciences Corporation

Forward Citations = 110

76 inventors:

goldMedal Mark W Holladay (17 out of 25 patents)

silverMedal Eduardo Setti (12 out of 19 patents)

bronzeMedal Qi Chao (11 out of 26 patents)

4.  Martin W Rowbottom (10 out of 41 patents)

5.  Shripad S Bhagwat (9 out of 43 patents)

Please report any incorrect information to support@idiyas.com
Loading…